Skip to content

Plain-English explainer

"Ozempic Burps" & Acid Reflux: Why It Happens & What Helps

By Updated

We keep this plain-English — no jargon, every claim sourced.

On this page

Featured partner

CoreAge Rx

$99/mo flat

Doctor-reviewed semaglutide with one flat price and built-in human support.

Check availability
Category
Telehealth · semaglutide
Pricing
Flat monthly price
Support
Nurse + dietitian consults
Labs
No labs required

Advertising disclosure · we may earn a commission at no extra cost to you.

Partner

Collective

The lowest medication figure reviewed here, and nobody pays only it: a $199 annual membership is required to buy at all and the headline leaves it out.

$59/mo drug + $199/yr membership

Check Collective availability

If you have started Ozempic or Wegovy and noticed more burping — sometimes with an unpleasant, sulfur or "rotten-egg" smell — plus a creeping sense of heartburn or reflux, you are not imagining it and you are not alone. These symptoms have become common enough online to earn the nickname "Ozempic burps." Ozempic and Wegovy contain semaglutide, but doses, formulations and trial populations differ; the frequency and severity of symptoms are not necessarily identical. This guide explains, honestly, why it happens, how often it actually shows up in the data, what tends to help, and — importantly — the small number of situations where reflux or vomiting is a signal to call your prescriber rather than ride it out. This is general education, not medical advice for your specific case.

What is known about burping, reflux and stomach emptying?

Semaglutide labeling states that it delays gastric emptying and lists burping and reflux among reported reactions34. That does not establish a single mechanism for every gut symptom or prove why a particular burp smells like sulfur.

One cited 20-week trial of semaglutide 2.4 mg found no evidence of delayed gastric emptying at week 20 using an indirect paracetamol-absorption measure1. That result does not rule out every gastric-emptying effect in every setting, but it should not be described as proof of a universal slowdown. Appetite and gastrointestinal physiology involve more than one pathway2.

The sources here do not establish that retained food routinely ferments in semaglutide users to cause hydrogen-sulfide burps, nor a proven pressure pathway explaining every reflux episode. Tell the clinician whether you mean gas, heartburn, regurgitation or a distinct symptom. Hiccups are not burps; our semaglutide hiccups guide explains the separate label finding and when persistent episodes need assessment.

What the evidence supports

How common is it, really?

Burping and reflux are real labeled effects, but they sit below the headline side effects in frequency. In Ozempic's and Wegovy's FDA prescribing information, the most common gastrointestinal adverse reactions are nausea, vomiting, diarrhea, constipation and abdominal pain; eructation (the medical term for burping) and gastresophageal reflux disease (GERD) are listed among the reported adverse reactions as well34. They are real, documented, and dose-related — just less frequent than nausea, which affects a large minority of users.

Spontaneous adverse-event reports and observational studies can identify signals but do not by themselves prove causation or provide an individual risk estimate. The cited matched cohort study concerned GLP-1 medicines, especially shorter-acting agents; its findings should not be treated as direct proof of a particular semaglutide mechanism56. Gastrointestinal events were reported during treatment escalation in trials and labeling, but a symptom that persists still deserves review478.

One honestly reassuring point: pooled trial data show that the medicine's benefit does not depend on having these symptoms — people lose weight whether or not they get GI side effects12. You do not have to suffer burps and reflux for the drug to be working.

What actually helps

These meal and habit measures are suggested in clinical guidance for gastrointestinal symptoms8. They may help comfort, but they are not a guaranteed treatment for a proven sulfur-burp mechanism:

  • Eat smaller meals, and stop at the first sign of fullness. Notice whether larger meals trigger symptoms for you, and discuss portions that you can comfortably tolerate.
  • Go lower-fat. Rich or fatty meals can aggravate symptoms for some people; our foods to avoid on Ozempic & Wegovy guide breaks down which categories trigger trouble and why.
  • Don't lie down after eating. Staying upright for two to three hours after a meal, and not eating right before bed, lets gravity help keep stomach contents down — standard, low-risk reflux advice that works especially well here.
  • Slow down and chew well. Eating fast and gulping air adds to both gas and fullness. Eating slowly reduces swallowed air and helps you notice fullness before you overshoot.
  • Ease up on the usual reflux aggravators — alcohol, large amounts of caffeine, carbonation, and very spicy foods. Alcohol is worth singling out because it is itself a gut irritant on a drug that already slows the stomach; we cover that interaction in alcohol on Wegovy & Ozempic.
  • Mind the titration. Symptoms cluster around dose increases, so if a step-up makes burps and reflux worse, that is expected — and prescribers can legitimately hold you at your current dose longer before going up. The slow dose ladder exists precisely to keep these effects tolerable; see semaglutide dosing & side effects for how the ramp works.

For heartburn that breaks through these measures, an over-the-counter antacid or acid reducer can help short-term — but clear it with your prescriber or pharmacist first, and don't use one continuously without medical input, because persistent reflux that needs ongoing treatment is itself worth a conversation.

When burps or reflux signal something that needs care

Mild symptoms and persistent or severe symptoms need different responses. Do not assume a new or worsening symptom is harmless because burping is listed in the label.

Persistent vomiting, early lasting fullness, bloating or bringing up food eaten hours earlier deserves assessment. Observational research has identified an association with gastroparesis, but cannot by itself establish causation or diagnose your symptoms9. See our gastroparesis guide for that separate question. Reports of retained stomach contents and pulmonary aspiration are reflected in current labeling; the label says available data do not establish a universal prevention or temporary-stopping schedule before anesthesia410. If you are scheduled for surgery, an endoscopy, or any procedure with anesthesia, tell the team you are on semaglutide — see stopping semaglutide before surgery & anesthesia for what current guidance advises.

Call your prescriber promptly for: vomiting you can't keep ahead of or that won't stop; reflux severe or persistent enough to disrupt sleep or eating; trouble swallowing, or food/pills feeling stuck; or severe, persistent abdominal pain — especially if it radiates to the back, with or without vomiting, which can be a sign of pancreatitis and is an urgent symptom, not a reflux one3. Frequent, long-standing reflux also deserves evaluation in its own right because, untreated over time, it can damage the esophagus. Take these symptoms seriously rather than waiting them out.

A label-listed symptom does not establish the cause or safety of your own episode. If changes to meals do not help, ask for assessment rather than assuming the problem will resolve or using an acid reducer indefinitely.

A note on compounded semaglutide

The label findings concern FDA-approved Ozempic and Wegovy34. A compounded product is not the product tested in those trials; do not transfer exact rates or assume the same tolerability. Confirm the formulation and dose with the prescriber or pharmacist. If you are weighing where to get semaglutide, our best semaglutide providers guide compares options on price and oversight.

The honest bottom line

Burping and reflux are reported in semaglutide labeling, but the evidence here does not prove a specific sulfur-gas mechanism or guarantee that symptoms settle with behavioral changes34. Meal size, food triggers, posture and a prescriber-led treatment review can be useful topics to discuss8. If coffee appears to trigger your symptoms, our caffeine guide covers that separate question. The genuine red flags are persistent vomiting, food not moving, severe or radiating abdominal pain, or trouble swallowing — and always disclose semaglutide use before any procedure with anesthesia910. When in doubt, ask your prescriber rather than self-adjust. If you take an oral contraceptive and vomit, follow the instructions for your exact pill; timing and backup requirements differ. Our semaglutide and birth-control guide explains that separate issue. For the full evidence picture on how semaglutide works, its results and its safety profile, see our pillar guide, Semaglutide: How It Works, Results & Side Effects.

A few more quick ones

What causes “Ozempic burps”?

Burping is reported in semaglutide labeling. Semaglutide can delay gastric emptying, but the evidence here does not establish one mechanism for every person’s burping or a specific sulfur smell.

Why do the burps smell like sulfur or rotten eggs?

The sources here do not establish a semaglutide-specific explanation for that smell. They do not prove that retained food routinely ferments to produce it. Report persistent or worsening symptoms and any pain, vomiting or trouble swallowing.

Does Ozempic or Wegovy cause acid reflux?

Reflux and burping are listed among reported reactions. That does not guarantee identical effects across brands, doses or formulations, or establish the cause of an individual episode.

How can I manage burping and reflux?

Smaller meals, identifying food triggers and remaining upright after meals may help. Discuss persistent symptoms and any acid-reducing medicine with your clinician or pharmacist. Do not independently change the semaglutide dose.

When should reflux or vomiting on semaglutide worry me?

Seek advice for persistent vomiting, difficulty swallowing or symptoms disrupting eating or sleep. Severe persistent abdominal pain, especially radiating to the back, needs urgent assessment. Tell anesthesia teams that you take semaglutide before a procedure.

Where this comes from

Sources include clinical studies, official labeling, and company pricing pages. Company-source links below lead to our provider pricing and source checks.

  1. Friedrichsen M, Breitschaft A, Tadayon S, et al. (2021). The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity.. Diabetes Obes Metab. https://pubmed.ncbi.nlm.nih.gov/33269530/
  2. Drucker DJ (2022). GLP-1 physiology informs the pharmacotherapy of obesity.. Mol Metab. https://pubmed.ncbi.nlm.nih.gov/34626851/
  3. Novo Nordisk Pharmaceutical Industries, LP (2026). OZEMPIC (semaglutide) injection, solution — FDA Prescribing Information (Adverse Reactions, incl. eructation and GERD).. DailyMed (NLM), FDA label. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79
  4. Novo Nordisk Pharmaceutical Industries, LP (2026). WEGOVY (semaglutide) injection / tablet — FDA Prescribing Information (Adverse Reactions, incl. eructation and gastroesophageal reflux disease).. DailyMed (NLM), FDA label. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
  5. Liu L, Chen J, Wang L, et al. (2022). Association between different GLP-1 receptor agonists and gastrointestinal adverse reactions: A real-world disproportionality study based on FDA adverse event reporting system database.. Front Endocrinol (Lausanne). https://pubmed.ncbi.nlm.nih.gov/36568085/
  6. Liu BD, Udemba SC, Liang K, et al. (2024). Shorter-acting glucagon-like peptide-1 receptor agonists are associated with increased development of gastro-oesophageal reflux disease and its complications in patients with type 2 diabetes mellitus: a population-level retrospective matched cohort study.. Gut. https://pubmed.ncbi.nlm.nih.gov/37739778/
  7. Wilding JPH, Batterham RL, Calanna S, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1).. N Engl J Med. https://pubmed.ncbi.nlm.nih.gov/33567185/
  8. Wharton S, Davies M, Dicker D, et al. (2022). Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practice.. Postgrad Med. https://pubmed.ncbi.nlm.nih.gov/34775881/
  9. Sodhi M, Rezaeianzadeh R, Kezouh A, Etminan M (2023). Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss.. JAMA. https://pubmed.ncbi.nlm.nih.gov/37796527/
  10. Jalleh RJ, Jones KL, Rayner CK, et al. (2024). Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide.. J Clin Endocrinol Metab. https://pubmed.ncbi.nlm.nih.gov/39418085/
  11. Nadeem D, Taye M, Still M, et al. (2024). Effects of glucagon-like peptide-1 receptor agonists on upper endoscopy in diabetic and nondiabetic patients.. Gastrointest Endosc. https://pubmed.ncbi.nlm.nih.gov/38692518/
  12. Ahrén B, Atkin SL, Charpentier G, et al. (2018). Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials.. Diabetes Obes Metab. https://pubmed.ncbi.nlm.nih.gov/29766634/

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.